Latest news
Will Newly Approved Centanafadine Transform ADHD Care? - Physician's WeeklyPhysician's Weekly · Fri, 07 Aug 2026 14:40:03 GMT3 Psychiatry Headlines You Missed in July 2026 - HCPLiveHCPLive · Tue, 04 Aug 2026 21:05:12 GMTThe HCPFive: Top News for Healthcare Providers from the Week of 07/26 - HCPLiveHCPLive · Mon, 03 Aug 2026 20:44:09 GMTCentanafadine in ADHD: Clinical Significance of the First Triple Reuptake Inhibitor for ADHD - Psychiatric TimesPsychiatric Times · Mon, 03 Aug 2026 18:23:02 GMTFDA Approves First-in-Class Centanafadine for ADHD in Adults and Pediatric Patients - Pharmacy TimesPharmacy Times · Mon, 03 Aug 2026 16:09:45 GMTADHD: FDA Approves New CNS Drug Simtriyo for Adults and Children - HealthlineHealthline · Wed, 29 Jul 2026 07:00:00 GMTFDA Approves ‘First-in-Class’ NDSRI for ADHD in Adults and Children - AOL.comAOL.com · Wed, 29 Jul 2026 07:00:00 GMTCentanafadine Receives FDA Approval for the Treatment of ADHD - ADDitudeADDitude · Wed, 29 Jul 2026 07:00:00 GMT